Grant: Discovery Grants Program - Individual
The University of British Columbia
$28,000.00
Natural and accelerated aging of the eNOS-caveolin-1 system
FY 2024-25
Summary
Endothelium-derived nitric oxide (NO) is a critical negative regulator of smooth muscle cell (SMC) constriction. The OVERALL OBJECTIVE of my research program is to better understand the regulation of the endothelial NO synthase (eNOS/NOS3), the endothelial source of agonist-induced NO release. We have extensively published on how eNOS is negatively regulated by caveolae coat protein caveolin-1 (Cav-1) and its 20 amino acid scaffolding domain (CSD), and even how a mutant cell-permeable CSD peptide called CavNOxin with `dominant-negative'-like properties can drastically increase vasodilatory NO release by preventing the inhibitory clamp of Cav-1 on eNOS.
However, unpublished observations revealed that the near complete (>80%) NO-dependent inhibition of vascular contractility with CavNOxin is exclusively observed in aged vessels from >10mo old mice, whereas vessels from 2mo old mice show no (0%) vasodilatory effect. Moreover, recent whole mount microscopy experiments using intact vessels have shown that eNOS' well-documented perinuclear Golgi localization is drastically altered in aging vasculature, taking a more diffuse and punctate appearance that is reminiscent of Cav-1 staining. These black-and-white differences in old vs young tissues suggest the presence of profound changes to the eNOS-Cav-1 system in aging vasculature, a novel concept in endothelial biology. More importantly, we postulate that the aging vascular endothelium undergoes planned fragmentation of its Golgi apparatus - a common topic in other fields - resulting in eNOS mislocalization and changes to interactions with some of its critical co-factors including inhibitory Cav-1. Whether this chain of events affects the release of other endothelial vasodilators is unknown.
THE IMPORTANT KNOWLEDGE GAPS we will address: we will determine whether vascular aging causes planned endothelial Golgi fragmentation, and how this correlates with or even causes changes in eNOS localization and interaction with the Cav-1/caveolae system. We will also study how this chain of events may directly affect the dynamic endothelial response to CavNOxin and therefore imply causality.
We propose the FOLLOWING OBJECTIVES:
1: Confirm that vascular aging correlates with greater endothelial Golgi fragmentation, eNOS mislocalization and greater interaction with Cav-1, resulting in lower endothelial vasodilatory function and enhanced CavNOxin response.
2: Show that angiotensin II infusion and other models of accelerated vascular aging expedite eNOS mislocalization, dysfunction of the eNOS/Cav-1 and Golgi apparatus fragmentation.
3: Determine whether forced eNOS NO release may activate a feedback loop that prevents vascular aging and downstream Golgi fragmentation.
Our LONG-TERM VISION includes a better understanding of how endothelial cell homeostasis changes with age and how this might be linked to improvements in vascular tone control - which will benefit an aging Canadian population.
Program
Discovery Grants Program - Individual
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2022-04815
Name nom
Bernatchez, Pascal
Department département
Pharmacology and Therapeutics
Organization id
2
Institution établissement
The University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2022
Award amount
28000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5506
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal circulation
Research subject fr
Circulation animale
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Natural and accelerated aging of the eNOS-caveolin-1 system
Keywords
nitric oxide; endothelium; vasodilation; caveolin; golgi apparatus; caveolae
Application summary
Endothelium-derived nitric oxide (NO) is a critical negative regulator of smooth muscle cell (SMC) constriction. The OVERALL OBJECTIVE of my research program is to better understand the regulation of the endothelial NO synthase (eNOS/NOS3), the endothelial source of agonist-induced NO release. We have extensively published on how eNOS is negatively regulated by caveolae coat protein caveolin-1 (Cav-1) and its 20 amino acid scaffolding domain (CSD), and even how a mutant cell-permeable CSD peptide called CavNOxin with `dominant-negative'-like properties can drastically increase vasodilatory NO release by preventing the inhibitory clamp of Cav-1 on eNOS.
However, unpublished observations revealed that the near complete (>80%) NO-dependent inhibition of vascular contractility with CavNOxin is exclusively observed in aged vessels from >10mo old mice, whereas vessels from 2mo old mice show no (0%) vasodilatory effect. Moreover, recent whole mount microscopy experiments using intact vessels have shown that eNOS' well-documented perinuclear Golgi localization is drastically altered in aging vasculature, taking a more diffuse and punctate appearance that is reminiscent of Cav-1 staining. These black-and-white differences in old vs young tissues suggest the presence of profound changes to the eNOS-Cav-1 system in aging vasculature, a novel concept in endothelial biology. More importantly, we postulate that the aging vascular endothelium undergoes planned fragmentation of its Golgi apparatus - a common topic in other fields - resulting in eNOS mislocalization and changes to interactions with some of its critical co-factors including inhibitory Cav-1. Whether this chain of events affects the release of other endothelial vasodilators is unknown.
THE IMPORTANT KNOWLEDGE GAPS we will address: we will determine whether vascular aging causes planned endothelial Golgi fragmentation, and how this correlates with or even causes changes in eNOS localization and interaction with the Cav-1/caveolae system. We will also study how this chain of events may directly affect the dynamic endothelial response to CavNOxin and therefore imply causality.
We propose the FOLLOWING OBJECTIVES:
1: Confirm that vascular aging correlates with greater endothelial Golgi fragmentation, eNOS mislocalization and greater interaction with Cav-1, resulting in lower endothelial vasodilatory function and enhanced CavNOxin response.
2: Show that angiotensin II infusion and other models of accelerated vascular aging expedite eNOS mislocalization, dysfunction of the eNOS/Cav-1 and Golgi apparatus fragmentation.
3: Determine whether forced eNOS NO release may activate a feedback loop that prevents vascular aging and downstream Golgi fragmentation.
Our LONG-TERM VISION includes a better understanding of how endothelial cell homeostasis changes with age and how this might be linked to improvements in vascular tone control - which will benefit an aging Canadian population.